Price $2.18 |
Market Cap
6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.21
|
P/S
0.12
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-7.5K
|
FCF
-0.5
|
|
Op. Margin
-34.40%
|
Net Margin
-35.10%
|
ROE
-52.30%
|
ROI
-6.30%
|
|
ROA
-30.40%
|
EPS Growth
-477.80%
|
Current Ratio
3.9
|
Debt/Equity
3.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aquestive Therapeutics Inc (AQST) | $2.06 | - | - | 63.1M | Strong Buy |
| Icoreconnect Inc (ICCT) | $0.16 | - | - | 21.2M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $2.60 | - | - | 4.8M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.27 | - | - | 16.4M | Strong Buy |
| Invo Bioscience Inc (INVO) | $0.30 | - | - | 8.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
